Drug Name: | Edoxaban |
---|
Drug Class: | Direct oral anticoagulant (DOAC) |
---|
Mechanism of Action: | Factor Xa inhibitor |
---|
Use: | - Prevention of stroke and systemic embolism in non-valvular atrial fibrillation
- Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Reduction of risk of recurrent DVT and PE
|
---|
Side Effects: | - Bleeding
- Anemia
- Nausea
- Headache
- Fatigue
|
---|
Contraindications: | - Active bleeding
- Severe renal impairment (CrCl < 15 mL/min)
- Hepatic impairment (Child-Pugh B or C)
|
---|
Specialty: | - Cardiology
- Hematology
- Internal Medicine
|
---|